Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial

Launched by GEORGE WASHINGTON UNIVERSITY · Sep 29, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how pregnant women feel about two different types of supplements: one that contains iron and is called Iron Folic Acid (IFA) and another that has multiple vitamins and minerals, also with iron, called Multiple Micronutrient Supplementation (MMS). The researchers want to see which supplement women prefer, how they feel about taking them, and if they experience any side effects. This study is important because good nutrition during pregnancy is crucial for the health of both the mother and the baby.

To participate in this trial, you need to be a pregnant woman who is less than 15 weeks along, at least 18 years old, and able to stay in the study area for the entire duration of the trial. You should also be attending your first antenatal care visit at the study clinic and provide informed consent to join. However, if you have severe anemia, certain genetic blood disorders, or are already in another nutrition study, you won’t be able to take part. If you do join, you can expect to try both types of supplements during the study and share your thoughts on them. This information will help improve nutrition support for pregnant women in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Attending first ANC visit at the study clinic
• • Pregnant women ≤ 15 weeks of gestation
• • Aged ≥ 18 years
• • Intending to stay in the study area for the duration of study
• • Provides informed consent
• Exclusion Criteria:
• • Severe anemia (defined as Hb \<8.5 g/dL per Tanzania standard of care)
• • Sickle cell disease (SS,SC, CC genotype) as tested by HemoTypeSC
• • Concurrent participation in other nutritional supplementation trial
• • Pregnant women with disability or condition which would impair their ability to provide informed consent and complete study procedures.